|
|
Article: China Pharma Holdings, Inc. Announces SFDA Approval for Production of Omeprazole Injections.
- Article from:
- PR Newswire
- Article date:
- August 18, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Broadens Product Offerings for Multiple Therapeutic Markets
HAIKOU CITY, China, Aug. 18 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (BULLETIN BOARD: CPHI) , which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it has received approval from the Chinese State Food and Drug Administration ("SFDA) for the production of generic Omeprazole Sodium injections.
Omeprazole is widely utilized to treat gastroesophageal reflux disease (GERD), and is highly effective in other conditions caused by excess acidic formulations in the stomach, including gastric ulcers, recurrent duodenal ...
Related newspaper, magazine, and journal articles:
|
|
Article: China Pharma Holdings, Inc. to Present at ...
PR Newswire;
July 2, 2008 ;
700+ words
... ... Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. (''China Pharma'') (BULLETIN ... www.collins-stewart.com/ . About China Pharma Holdings, Inc. China Pharma Holdings, Inc. develops, manufactures, and markets ...
|
|